Well, isn’t that interesting?

And completely predictable. 

Courtesy of HuffPo:

President Donald Trump reportedly owns a stake in a company that produces hydroxychloroquine, the anti-malaria drug he has repeatedly touted as a coronavirus treatment even though his experts say there’s no strong evidence it works.

Trump “has a small personal financial interest” in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine, The New York Times reported Monday.

In addition, Sanofi’s largest shareholders include a mutual fund company run by major Republican donor Ken Fisher, the paper said. Trump’s three family trusts, as of last year, each had investments in a mutual fund whose largest holding was Sanofi, according to the Times. Commerce Secretary Wilbur Ross also had ties to the drugmaker, the Times reported.

Trump’s “assertiveness” in promoting the drug contrary to the recommendation of top health experts “has raised questions about his motives,” the Times noted.

A chorus of Trump supporters with no medical expertise have backed the president’s urging of doctors to treat COVID-19 patients with the drug, including his personal lawyer, Rudy Giuliani, and Fox News host Sean Hannity.

In the face of warnings from top infectious disease expert Dr. Anthony Fauci that the drug’s safety and effectiveness are uncertain in treating COVID-19, Trump has continued to laud its supposed benefits.

“What do you have to lose?” he asked at a press briefing this week urging those sick with the virus to take the drug.

Actually there is quite a bit you could lose as the side effects include difficulty breathing, hair loss, itchy skin, blurred vision, and in extreme cases even death. 

But it is not so much what we have to lose in this case, but what Trump has to gain if this becomes the go to medication for treating this virus. 

And what he has to gain is potentially millions of dollars. 

I don’t know about you but the idea of Donald Trump benefiting financially from this pandemic sickens me to my core.